Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IFOSFAMIDE for Angiosarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 53 adverse event reports in the FDA FAERS database where IFOSFAMIDE was used for Angiosarcoma.

Most Reported Side Effects for IFOSFAMIDE

Side Effect Reports % Deaths Hosp.
Off label use 2,281 13.4% 486 629
Febrile neutropenia 2,225 13.1% 228 1,165
Disease progression 1,912 11.2% 515 198
Neutropenia 1,509 8.9% 173 417
Drug ineffective 1,331 7.8% 416 317
Thrombocytopenia 1,227 7.2% 140 317
Anaemia 1,067 6.3% 94 365
Product use in unapproved indication 890 5.2% 190 183
Pyrexia 752 4.4% 107 493
Sepsis 712 4.2% 406 273
Malignant neoplasm progression 671 4.0% 210 120
Infection 649 3.8% 177 113
Pancytopenia 632 3.7% 144 270
Encephalopathy 585 3.4% 72 287
Vomiting 570 3.4% 80 274

Other Indications for IFOSFAMIDE

Diffuse large b-cell lymphoma (2,425) Ewing's sarcoma (937) Product used for unknown indication (910) Osteosarcoma (845) B-cell lymphoma (541) Hodgkin's disease (533) Burkitt's lymphoma (472) Non-hodgkin's lymphoma (434) Chemotherapy (429) Central nervous system lymphoma (394)

Other Drugs Used for Angiosarcoma

PAZOPANIB (164) PACLITAXEL (148) DOXORUBICIN (126) DOCETAXEL (94) GEMCITABINE (67) SIROLIMUS (59) NIVOLUMAB (46) PEMBROLIZUMAB (37) BEVACIZUMAB (36) CABOZANTINIB S-MALATE (27)

Related Pages

IFOSFAMIDE Full Profile All Angiosarcoma Drugs IFOSFAMIDE Demographics IFOSFAMIDE Timeline